University of Kansas Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.
University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.
Top-decile sponsor footprint
University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 9 of 9
Self Care TALK Study - Promoting Stroke Caregiver Health
NCT00646217
Brain Aging Project--Kansas University
NCT00267124
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
NCT00594620
Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
NCT00222131
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
NCT00056082
Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
NCT00033345
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
NCT00005879
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
NCT00005886
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 45 |
| Phase 3 | 9 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Kansas Medical Center pipeline
93 recruiting of 408 indexed (23% open); 252 completed (62%).
Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).
Top condition: Smoking Cessation (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kansas Medical Center: open-pipeline peers nationwide
Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Texas at Austin · 23% recruiting · 257 trials
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
Related
What to do with this University of Kansas Medical Center page
408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.
- 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.